This systematic review synthesizes the evidence from 14 studies on medication reconciliation in cancer patients. While the majority of studies did not include a contemporaneous comparison group, they did report that medication reconciliation led to medication error identification (most frequently drug omissions, additions or dosage errors) in up to 88-95% of patients.

Researchers conducted a systematic review of simulation training efforts to improve medication safety. Simulation training reduced errors but was rarely more effective than hands-on didactics. A past PSNet perspective evaluated whether simulation meaningfully adds to teamwork training programs.

This case series study describes 10 medication errors related to cancer treatment that were investigated using an approach incorporating root cause analysis and a morbidity and mortality conference. This process resulted in the proposal of multiple corrective actions, suggesting that it identifies actionable safety concerns.

Complex chemotherapy regimens were associated with an increased risk of prescribing errors, in this analysis of data from a previously published study on the incidence of chemotherapy medication errors.

This observational study, conducted at a French hospital, found that most chemotherapy medication errors resulted in near misses and did not cause harm to patients.